Compare StocksPFE vs TPR

Pfizer Inc. (PFE) vs Tapestry, Inc. (TPR): Which Is the Better Buy in 2026?

As of 2026-06-19, PFE is overvalued at $25, with a DCF intrinsic value of $22 and a margin of safety of -12%. TPR is overvalued at $144, with an intrinsic value of $23 and a margin of safety of -534%. Of the two, PFE has the wider margin of safety.

PFE
Pfizer Inc.
$25.21
VS
TPR
Tapestry, Inc.
$143.50

Rewards

PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.
TPR
  • Gross margin of 76.2% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Tapestry, Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Free cash flow has grown at a 12.9% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.
TPR
  • FCF yield of 5.3% suggests reasonable valuation assuming continued moderate growth.
  • High leverage (4.18x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
  • Insiders have sold $6.4M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
PFE
TPR
Valuation
$12.38B
Free Cash Flow
$1.53B
8.61%
FCF Yield
5.28%
19.24
Trailing P/E
43.62
8.91
Forward P/E
18.54
Quality & Moat
10.19%
ROIC
30.19%
8.31%
ROE
60.91%
74.80%
Gross Margin
76.18%
13.77
PEG Ratio
0.31
Balance Sheet Safety
0.57
Net Debt / Equity
4.18
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.45
6.61%
Dividend Yield
1.06%
PFE: 6Ties: 2TPR: 4
PFETPR

Historical Fundamentals

Learn more →
PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

TPR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
TPR
$16.88
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.03B
Δ Market Cap
+$17.40B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
TPR
534.3% Overvalued
Price is 534.3% above estimated fair value
Current Price: $143.50
Fair Value: $22.62
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

TPR

What growth rate is the market pricing in at $144?

+31.5%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.3%

The market implies +31.5% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
TPR
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Margin Stability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
TPR
-3.01
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,744
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
TPR
Insiders 0.3%Institutions 98.0%Retail & Other 1.7%
No. of Institutional Holders1,492
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises
TPR
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
TPR
2
Sells (3M)
19
Sells (12M)
Total value (12M): $46.08M
KAHN TODD LEONARD
Officer
$2.74M
@ $140.02 · 2026-05-26
CREVOISERAT JOANNE C
Chief Executive Officer
$3.69M
@ $132.89 · 2026-05-13
DADLANI MANESH
Officer
$152,149
@ $156.05 · 2026-03-03
CREVOISERAT JOANNE C
Chief Executive Officer
$7.56M
@ $154.87 · 2026-02-18
GRECO THOMAS R
Director
$2.20M
@ $154.44 · 2026-02-17
DADLANI MANESH
Officer
$329,492
@ $153.47 · 2026-02-11
ROE SCOTT A
Chief Operating Officer
$6.76M
@ $152.62 · 2026-02-10
GATES ANNE
Director
$999,327
@ $153.79 · 2026-02-10
KULIKOWSKY DENISE
Officer
$1.43M
@ $155.62 · 2026-02-10
KAHN TODD LEONARD
Officer
$6.03M
@ $151.34 · 2026-02-09
KULIKOWSKY DENISE
Officer
$67,144
@ $115.17 · 2025-12-04
KULIKOWSKY DENISE
Officer
$184,133
@ $110.19 · 2025-11-26
KAHN TODD LEONARD
Officer
$1.11M
@ $107.00 · 2025-11-24
ROE SCOTT A
Chief Operating Officer
$1.97M
@ $104.85 · 2025-11-21
CREVOISERAT JOANNE C
Chief Executive Officer
$3.34M
@ $105.31 · 2025-11-21
KAHN TODD LEONARD
Officer
$2.98M
@ $102.83 · 2025-11-18
HOWARD DAVID E
Officer
$2.57M
@ $102.50 · 2025-11-18
LAU KA MING ALAN
Director
$1.20M
@ $106.19 · 2025-09-11
DADLANI MANESH
Officer
$780,712
@ $99.05 · 2025-08-25
DADLANI MANESH
Officer
$137,260
@ $82.29 · 2025-05-13
KAHN TODD LEONARD
Officer
$3.26M
@ $81.40 · 2025-05-12
KAHN TODD LEONARD
Chief Executive Officer
$3.58M
@ $84.71 · 2025-02-26
KAHN TODD LEONARD
Officer
$681,976
@ $87.59 · 2025-02-21
ROE SCOTT A
Chief Operating Officer
$2.23M
@ $86.56 · 2025-02-20
HOWARD DAVID E
General Counsel
$1.05M
@ $88.00 · 2025-02-20
KAHN TODD LEONARD
Officer
$4.19M
@ $58.68 · 2024-11-25
HOWARD DAVID E
General Counsel
$2.48M
@ $58.95 · 2024-11-22
DADLANI MANESH
Officer
$514,219
@ $57.96 · 2024-11-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
TPR
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
TPR
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View PFE Full AnalysisView TPR Full Analysis

Frequently Asked Questions: PFE vs TPR

Is Pfizer Inc. or Tapestry, Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a -12.3% margin of safety (intrinsic value $22 vs. price $25), compared to TPR's -534.3% margin of safety (intrinsic $23 vs. $144).

Which stock has a wider economic moat, Pfizer Inc. or Tapestry, Inc.?

TPR scores 82/100 (Wide moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Pfizer Inc. in financial distress?

PFE's Altman Z-Score of 2.1 places it in the Grey zone, signaling elevated bankruptcy risk. TPR scores 4.2 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Pfizer Inc. or Tapestry, Inc.?

Pfizer Inc. (PFE) generates a 8.6% free cash flow yield, compared to Tapestry, Inc.'s 5.3%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Pfizer Inc. or Tapestry, Inc.?

TPR earns 30.2% ROIC versus PFE's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Pfizer Inc.'s or Tapestry, Inc.'s?

TPR's dividend earns a safety score of 54/100 (Borderline), compared to PFE's 24/100 (Unsafe). TPR has raised its dividend for 3 consecutive years.